Bright Angel Therapeutics
Toronto
About Bright Angel Therapeutics
Bright Angel Therapeutics is a developer of novel therapeutics designed to provide treatment of drug-resistant and life-threatening fungal infections. The company's services increases efficacy of current treatments and eradicates drug resistance by targeting the stress responses required by fungi for survival, virulence and drug resistance, enabling users to overcome the frequent emergence of clinical resistance largely responsible for the severe morbidity and mortality associated with infection by diverse fungal pathogens.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $100.0K
- Funding stage: Seed
- Last round: Grant (Dec 2020)
- Website: brightangeltherapeutics.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/bright-angel-therapeutics-163051 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.